Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 5810358, 2 pages
http://dx.doi.org/10.1155/2016/5810358
Editorial

Vascular Diseases and Metabolic Disorders

1Stem Cell Institute, Leuven University, 3000 Leuven, Belgium
2Beijing Key Laboratory of Diabetes Prevention and Research, Lu He Hospital, Capital Medical University, Beijing 101149, China
3Zhejiang University, Hangzhou 310027, China

Received 28 July 2016; Accepted 28 July 2016

Copyright © 2016 Ying-Mei Feng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American Heart Association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. R. S. Patel, Q. Li, N. Ghasemzadeh et al., “Circulating CD34+ progenitor cells and risk of mortality in a population with coronary artery disease,” Circulation Research, vol. 116, no. 2, pp. 289–297, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. S. S. Hayek, J. MacNamara, A. S. Tahhan et al., “Circulating progenitor cells identify peripheral arterial disease in patients with coronary artery disease,” Circulation Research, 2016. View at Publisher · View at Google Scholar
  4. M. Aguilar, T. Bhuket, S. Torres, B. Liu, and R. J. Wong, “Prevalence of the metabolic syndrome in the United States, 2003–2012,” The Journal of the American Medical Association, vol. 313, no. 19, pp. 1973–1974, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. Jeon, W. G. Kim, Y. M. Choi et al., “Recent changes in the clinical outcome of papillary thyroid carcinoma with cervical lymph node metastasis,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 9, pp. 3470–3477, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. J. V. Virbasius and M. P. Czech, “Map4k4 signaling nodes in metabolic and cardiovascular diseases,” Trends in Endocrinology & Metabolism, vol. 27, no. 7, pp. 484–492, 2016. View at Publisher · View at Google Scholar
  7. P. Willeit, P. Skroblin, S. Kiechl, C. Fernández-Hernando, and M. Mayr, “Liver microRNAs: potential mediators and biomarkers for metabolic and cardiovascular disease?” European Heart Journal, 2016. View at Publisher · View at Google Scholar
  8. P. Laurila, J. Soronen, S. Kooijman et al., “USF1 deficiency activates brown adipose tissue and improves cardiometabolic health,” Science Translational Medicine, vol. 8, no. 323, Article ID 323ra13, 2016. View at Publisher · View at Google Scholar
  9. S. Golpanian, A. Wolf, K. E. Hatzistergos, and J. M. Hare, “Rebuilding the damaged heart: mesenchymal stem cells, cell-based therapy, and engineered heart tissue,” Physiological Reviews, vol. 96, no. 3, pp. 1127–1168, 2016. View at Publisher · View at Google Scholar